ASRS: Apples and Oranges: Comparing “Real-World” And Clinical Trial Outcomes
The average patient with neovascular age-related macular degeneration (nvAMD) would not qualify for the trials that determine current standards of care. Clinical trial methodology could be to blame for real-world patients having...
Read More